Dutch Gold Resources (DGRI) 0.0001 $DGRI
Dutch Gold Resources Enters Continuing Medical Education Market
Marketwired - Tue Mar 31, 8:02AM CDT
Dutch Gold Resources, Inc. (OTC PINK: DGRI) (the "Company"

(http://dutchgoldinc.com) today announced that its subsidiary, Ascendant Therapeutics, Inc., entered the Continuing Medical Education market and will soon launch two accredited courses for healthcare providers in the United States and Canada.
Dr. Michelle Reillo to Address the NY State CBD Educational Series: CBD and Implications for Health, The Cannabinoid Manual
Marketwired - Thu Jan 15, 8:32AM CST
Dutch Gold Resources, Inc. (OTC PINK: DGRI) (the "Company"

(http://dutchgoldinc.com) today announced that the author of The Cannabinoid Manual, Dr. Michelle Reillo will be a featured speaker at the New York State CBD Educational Series. The event, hosted by New York State CBD, will include physicians, researchers, and scientists, participating in a leading edge discussion of the role of Cannabidiol in healthcare.
The Cannabinoid Manual Publishing Rollout Begins
Marketwired - Thu Jan 08, 3:37PM CST
Dutch Gold Resources, Inc. (OTC PINK: DGRI) (the "Company"

(http://dutchgoldinc.com) today announced that its subsidiary, Ascendant Therapeutics, Inc., has completed the initial draft of its new book, The Cannabinoid Manual, by Dr. Michelle Reillo. The Company will host a webinar on Tuesday, January 13, 2015 at 2PM EST, to introduce Dr. Reillo, where she will discuss the development of the manual and how health care professionals and consumers might use the book.
Dutch Gold to Host Investor Conference Call
Marketwired - Mon Dec 08, 8:08AM CST
Dutch Gold Resources, Inc. (OTC PINK: DGRI) (the "Company"

(http://dutchgoldinc.com) today announced that it will hold a Conference Call for investors on December 12, 2014 at 2PM EST.
Dutch Gold Develops Neuroprotective Protocols for Athletic Concussion Treatment
Marketwire - Thu Oct 02, 9:53AM CDT
Dutch Gold Resources, Inc. (PINKSHEETS: DGRI) (the "Company"

(http://dutchgoldinc.com) today announced that it has developed treatment protocols for Chronic Traumatic Encephalopathy (CTE) using Cannabidiol (CBD). The Company will begin offering certification programs for physicians, athletic trainers, and other healthcare professionals on December 4, 2014.